| Literature DB >> 27718056 |
Abstract
Histamine is a pro-inflammatory mediator with a prominent role in allergic diseases. Antagonists at the histamine receptor subtype 1 are central in anti-allergic therapies, with the exception of allergic asthma, where they are clinically without effect. The latest identified histamine receptor subtype 4, which is expressed mainly in hematopoietic cells, now provides a reasonable target for new therapeutic strategies inhibiting histamine function. The pathophysiology of allergy, esp. allergic asthma, and in its context the effects of antagonists at the histamine receptor subtype 4 in preclinical and clinical settings are discussed in this chapter.Entities:
Keywords: Allergy; Asthma; Dendritic cell; Sensitization; T cell
Mesh:
Substances:
Year: 2017 PMID: 27718056 DOI: 10.1007/164_2016_11
Source DB: PubMed Journal: Handb Exp Pharmacol ISSN: 0171-2004